Saniona AB
SANION.ST
| Exchange: | ST |
| Currency | Swedish krone |
| ISIN: | SE0005794617 |
| LEI: | 549300XO4L9XNOCFCZ84 |
| Fiscal Year End: | December |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Saniona AB (publ), a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico. It also develops medicines modulating ion channels. The company's products include Tesofensine, a monoamine reuptake inhibitor that has completed Phase 3 clinical trial to treat people with obesity; and Tesomet, an oral investigational therapy, which is Phase 2b clinical trial for the treatment of hypothalamic obesity and Prader-Willi syndrome. It also develops SAN711, a positive allosteric modulator of GABAA a3 containing receptors that has completed Phase 1 clinical trial for the treatment of absence seizures; SAN903, a novel medicine based on inhibition of the calcium-activated potassium ion channel, which has completed preclinical development for the treatment of inflammatory bowel disease; and SAN2219, a subtype selective positive allosteric modulator of GABAA a2- a3- and a5 that is in preclinical stage for treatment of acute repetitive seizures. In addition, the company is developing SAN2355 to treat refractory focal onset seizures; SAN2465 to treat major depressive disorder; and other programs to treat epilepsy, Alzheimer's, schizophrenia, and migraine. It has research and collaboration agreements with Boehringer Ingelheim International Gmb H to research, develop, manufacture, and commercialize therapeutics; license agreement with Productos Medix, S.A. de C.V. develop and commercialize tesofensine and/or Tesomet; research services agreement and a collaboration agreement with Cephagenix Ap S to identigy and develop novel migraine treatments; and research collaboration with Astronau Tx to research, develop, manufacture, and commercialize therapeutics for Alzheimer's disease. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark. |
| Address: | Smedeland 26B, Glostrup, Denmark, 2600 |
| Website: | https://www.saniona.com |
| Full Time Employees: | 22 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 544510016 |
| Market Capitalization Mln: | 544.51 |
| EBITDA: | -61687000 |
| Wall Street Target Price: | 6 |
| Book Value: | 0.06 |
| Earnings Share: | -0.83 |
| Most Recent Quarter: | 2024-06-30 |
| Operating Margin TTM: | -2.00 |
| Return On Assets TTM: | -0.39 |
| Return On Equity TTM: | -6.90 |
| Revenue TTM: | 24878000 |
| Revenue Per Share TTM: | 0.28 |
| Quarterly Revenue Growth YOY: | 1.08 |
| Gross Profit TTM: | 10808000 |
| Diluted Eps TTM: | -0.83 |
| Quarterly Earnings Growth YOY: | 4.55 |
Valuation
| Price Sales TTM: | 21.88 |
| Price Book MRQ: | 61.84 |
| Enterprise Value: | 419569461 |
| Enterprise Value Revenue: | 16.86 |
| Enterprise Value Ebitda: | -1.12 |
Shares
| Shares Outstanding: | 111238000 |
| Shares Float: | 101309126 |
| Percent Insiders: | 28.84 |
| Percent Institutions: | 6.25 |
Technicals
| Beta: | 0.98 |
| 52 Week High: | 7.94 |
| 52 Week Low: | 1.73 |
| 50 Day MA: | 4.47 |
| 200 Day MA: | 3.12 |
Splits & Dividends
| Last Split Factor: | 3022:2557 |
| Last Split Date: | 2024-01-17 |
Earnings
| Report Date: | 2025-05-27 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Report Date: | 2025-02-27 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Report Date: | 2024-11-28 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Report Date: | 2024-08-29 |
| Date: | 2024-06-30 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -0.17 |
| Report Date: | 2024-05-29 |
| Date: | 2024-03-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -0.10 |
| Report Date: | 2024-02-29 |
| Date: | 2023-12-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -0.37 |
| Report Date: | 2023-11-30 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -0.38 |
| Report Date: | 2023-08-31 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -0.34 |
| Report Date: | 2023-05-25 |
| Date: | 2023-03-31 |
| Before After Market: | After Market |
| Currency: | SEK |
| Eps Actual: | -0.34 |
| Report Date: | 2023-02-23 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -0.65 |
| Report Date: | 2022-11-17 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | 0.28 |
| Report Date: | 2022-08-25 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -1.41 |
| Report Date: | 2022-05-25 |
| Date: | 2022-03-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -2.13 |
| Report Date: | 2022-02-24 |
| Date: | 2021-12-31 |
| Before After Market: | Before Market |
| Currency: | SEK |
| Eps Actual: | -2.07 |
| Report Date: | 2021-11-18 |
| Date: | 2021-09-30 |
| Currency: | SEK |
| Eps Actual: | -1.50 |
| Report Date: | 2021-08-26 |
| Date: | 2021-06-30 |
| Currency: | SEK |
| Eps Actual: | -1.66 |
| Report Date: | 2021-05-26 |
| Date: | 2021-03-31 |
| Currency: | SEK |
| Eps Actual: | -1.33 |
| Report Date: | 2021-02-25 |
| Date: | 2020-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.73 |
| Report Date: | 2020-11-30 |
| Date: | 2020-09-30 |
| Currency: | SEK |
| Eps Actual: | -1.24 |
| Report Date: | 2020-08-27 |
| Date: | 2020-06-30 |
| Currency: | SEK |
| Eps Actual: | -1.23 |
| Report Date: | 2020-05-06 |
| Date: | 2020-03-31 |
| Currency: | SEK |
| Eps Actual: | -0.96 |
| Report Date: | 2020-02-07 |
| Date: | 2019-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.10 |
| Report Date: | 2019-11-13 |
| Date: | 2019-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.84 |
| Report Date: | 2019-08-21 |
| Date: | 2019-06-30 |
| Currency: | SEK |
| Eps Actual: | -0.7 |
| Report Date: | 2019-05-29 |
| Date: | 2019-03-31 |
| Currency: | SEK |
| Eps Actual: | -0.87 |
| Report Date: | 2019-02-21 |
| Date: | 2018-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.86 |
| Report Date: | 2018-11-14 |
| Date: | 2018-09-30 |
| Currency: | SEK |
| Eps Actual: | 0.55 |
| Report Date: | 2018-08-22 |
| Date: | 2018-06-30 |
| Currency: | SEK |
| Eps Actual: | -0.72 |
| Report Date: | 2018-05-24 |
| Date: | 2018-03-31 |
| Currency: | SEK |
| Eps Actual: | -0.50 |
| Report Date: | 2018-02-21 |
| Date: | 2017-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.55 |
| Report Date: | 2017-11-15 |
| Date: | 2017-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.50 |
| Report Date: | 2017-08-23 |
| Date: | 2017-06-30 |
| Currency: | SEK |
| Eps Actual: | -0.56 |
| Report Date: | 2017-05-11 |
| Date: | 2017-03-31 |
| Currency: | SEK |
| Eps Actual: | -0.25 |
| Report Date: | 2016-12-31 |
| Date: | 2016-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.49 |
| Report Date: | 2016-09-30 |
| Date: | 2016-09-30 |
| Currency: | SEK |
| Eps Actual: | 1.07 |
| Report Date: | 2016-06-30 |
| Date: | 2016-06-30 |
| Currency: | SEK |
| Eps Actual: | -0.40 |
| Report Date: | 2016-03-31 |
| Date: | 2016-03-31 |
| Currency: | SEK |
| Eps Actual: | -0.09 |
| Report Date: | 2015-12-31 |
| Date: | 2015-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.18 |
| Report Date: | 2015-09-30 |
| Date: | 2015-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.37 |
| Report Date: | 2015-06-30 |
| Date: | 2015-06-30 |
| Currency: | SEK |
| Eps Actual: | -0.25 |
| Report Date: | 2015-03-31 |
| Date: | 2015-03-31 |
| Currency: | SEK |
| Eps Actual: | -0.22 |
| Report Date: | 2014-12-31 |
| Date: | 2014-12-31 |
| Currency: | SEK |
| Eps Actual: | -0.25 |
| Report Date: | 2014-09-30 |
| Date: | 2014-09-30 |
| Currency: | SEK |
| Eps Actual: | -0.10 |
| Report Date: | 2014-06-30 |
| Date: | 2014-06-30 |
| Currency: | SEK |
| Eps Actual: | -0.04 |
| Date: | 2024-09-30 |
| Eps Actual: | -0.27 |
| Date: | 2023-12-31 |
| Eps Actual: | -1.44 |
| Date: | 2022-12-31 |
| Eps Actual: | -3.93 |
| Date: | 2021-12-31 |
| Eps Actual: | -6.57 |
| Date: | 2020-12-31 |
| Eps Actual: | -4.17 |
| Date: | 2019-12-31 |
| Eps Actual: | -2.51 |
| Date: | 2018-12-31 |
| Eps Actual: | -1.54 |
| Date: | 2017-12-31 |
| Eps Actual: | -1.88 |
| Date: | 2016-12-31 |
| Eps Actual: | 0.08 |
| Date: | 2015-12-31 |
| Eps Actual: | -1.05 |
| Date: | 2014-12-31 |
| Eps Actual: | -0.40 |